Extract from the Register of European Patents

EP About this file: EP1545467

EP1545467 - SOLID PHARMACEUTICAL FORMULATIONS COMPRISING TELMISARTAN [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  18.07.2008
Database last updated on 19.03.2026
Most recent event   Tooltip18.07.2008No opposition filed within time limitpublished on 20.08.2008  [2008/34]
Applicant(s)For all designated states
Boehringer Ingelheim International GmbH
Binger Strasse 173
55216 Ingelheim am Rhein / DE
[2005/26]
Inventor(s)01 / NAKATANI, Manabu
5-16 Matsugaoka-cho, Kawanishi
Hyogo 666-0037 / JP
02 / OHKI, Toshimitsu
4-25-40 Kouda, Ikeda
Osaka 563-0043 / JP
03 / TAKESHI, Sawada
2-2-19 Kouda, Ikeda
Osaka 563-0043 / JP
04 / TOYOSHIMA, Kenzo
7-25, Higashi-asahigaoka
Ikoma-shi, Nara-ken 630-0254 / JP
 [2005/26]
Application number, filing date03750572.418.09.2003
[2005/26]
WO2003EP10382
Priority number, dateDE200214468124.09.2002         Original published format: DE 10244681
[2005/26]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2004028505
Date:08.04.2004
Language:EN
[2004/15]
Type: A1 Application with search report 
No.:EP1545467
Date:29.06.2005
Language:EN
The application published by WIPO in one of the EPO official languages on 08.04.2004 takes the place of the publication of the European patent application.
[2005/26]
Type: B1 Patent specification 
No.:EP1545467
Date:12.09.2007
Language:EN
[2007/37]
Search report(s)International search report - published on:EP08.04.2004
ClassificationIPC:A61K9/16, A61K9/20, A61K31/4184
[2005/26]
CPC:
A61K9/209 (EP); A61K9/16 (KR); A61K31/4184 (EP,KR);
A61K9/1617 (EP); A61K9/1623 (EP); A61K9/1641 (EP);
A61K9/1652 (EP); A61K9/20 (KR); A61K9/2013 (EP);
A61K9/2018 (EP); A61K9/2031 (EP); A61K9/2054 (EP);
A61P31/04 (EP); A61P43/00 (EP); A61P9/02 (EP);
A61P9/12 (EP) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   RO,   SE,   SI,   SK,   TR [2005/26]
Extension statesALNot yet paid
LT25.04.2005
LV25.04.2005
MKNot yet paid
TitleGerman:FESTE PHARMAZEUTISCHE FORMULIERUNGEN MIT TELMISARTAN[2005/26]
English:SOLID PHARMACEUTICAL FORMULATIONS COMPRISING TELMISARTAN[2005/26]
French:FORMULATIONS PHARMACEUTIQUES SOUS FORME SOLIDE CONTENANT DU TELMISARTAN[2005/26]
Entry into regional phase25.04.2005National basic fee paid 
25.04.2005Designation fee(s) paid 
25.04.2005Examination fee paid 
Examination procedure03.04.2004Request for preliminary examination filed
International Preliminary Examining Authority: EP
25.04.2005Examination requested  [2005/26]
26.06.2006Despatch of a communication from the examining division (Time limit: M04)
24.10.2006Reply to a communication from the examining division
05.03.2007Communication of intention to grant the patent
16.07.2007Fee for grant paid
16.07.2007Fee for publishing/printing paid
Opposition(s)13.06.2008No opposition filed within time limit [2008/34]
Fees paidRenewal fee
30.09.2005Renewal fee patent year 03
02.10.2006Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.